MyFinsight
Home
Blog
About
Contact
Proceeds from issuance of
common stock
$149,291K
Net cash provided by
financing activities
$149,182K
Canceled cashflow
$109K
Net increase in
cash, cash...
$115,897K
Canceled cashflow
$33,285K
Payment of equity
issuance costs
$84K
Deemed dividend for
payments to third party on...
$25K
Share-based compensation
expense
$10,108K
Accrued liabilities
$3,672K
Depreciation and
amortization
$1,983K
Accounts payable
$1,725K
Reserve for lost
equipment and supplies
$699K
Amortization of debt
discounts and issuance...
$469K
Provision for
uncollectible accounts...
$365K
Loss on disposal of
property and equipment
-$167K
Disposable medical
equipment supplies
$130K
Non-cash lease expense
$125K
Other long-term
assets
-$10K
Refund of deposits for
medical rental...
$67K
Net cash used in
operating activities
-$18,366K
Net cash used in
investing activities
-$14,919K
Canceled cashflow
$19,453K
Canceled cashflow
$67K
Net loss
-$34,166K
Purchases of property and
equipment
$9,797K
Investment in equity
security
$5,000K
Deposits for medical
rental equipment
$189K
Accounts receivable
$2,661K
Prepaid expenses and
other current assets
$532K
Change in fair value of
warrant liabilities
-$232K
Operating lease
liabilities
-$228K
Back
Back
Cash Flow
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
source: myfinsight.com